| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/12/2001 | WO2001024828A2 MODULATORS OF CYTOKINE MEDIATED SIGNALLING PATHWAYS AND INTEGRIN αVβ3 RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024827A2 INHIBITORS OF THE ENDOTHELIN SIGNALLING PATHWAY AND αVβ3 INTEGRIN RECEPTOR ANTAGONISTS FOR COMBINATION THERAPY |
| 04/12/2001 | WO2001024815A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | WO2001024798A1 Use of central cannabinoid receptor antagonist for preparing medicines |
| 04/12/2001 | WO2001024797A1 Integrin receptor antagonists |
| 04/12/2001 | WO2001024796A1 1,2,4-triazole derivatives, composition, process of making and methods of use |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | WO2001024789A1 Agents for reducing cholesterol-uptake and liquid-uptake |
| 04/12/2001 | WO2001024782A2 Pharmaceutical agent for the treatment of cachexia and/or cardiogenic shock |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024681A2 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | WO2001024626A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | WO2000077190A3 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt |
| 04/12/2001 | WO2000056304A3 Anti-inflammatory uses of manzamines |
| 04/12/2001 | WO2000006199A8 Kvlqt1 - a long qt syndrome gene |
| 04/12/2001 | WO1999067283A3 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 04/12/2001 | DE19948428A1 Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel New LTB¶4¶ antagonist, process for its preparation and its use as a medicament |
| 04/12/2001 | DE19948126A1 Pharmazeutisches Mittel zur Behandlung von Kachexie und/oder kardiogenem Schock A pharmaceutical composition for the treatment of cachexia and / or cardiogenic shock |
| 04/12/2001 | DE19943634A1 Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2388487A1 Tissue plasminogen activator-like protease |
| 04/12/2001 | CA2388408A1 Prevention and treatment of diseases associated with blood coagulation |
| 04/12/2001 | CA2386540A1 Novel carbamates and ureas |
| 04/12/2001 | CA2386519A1 Ouabain-specific monoclonal antibodies |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386457A1 Inhibitors of the endothelin signalling pathway and .alpha.v.beta.3 integrin receptor antagonists for combination therapy |
| 04/12/2001 | CA2386383A1 Growth factor polypeptides and nucleic acids encoding same |
| 04/12/2001 | CA2386239A1 Methods for identifying rna binding compounds |
| 04/12/2001 | CA2386236A1 Human inwardly rectifying potassium channel subunit |
| 04/12/2001 | CA2386218A1 Triazine kinase inhibitors |
| 04/12/2001 | CA2386147A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/12/2001 | CA2386030A1 Integrin receptor antagonists |
| 04/12/2001 | CA2385972A1 Novel diarylamide derivatives and use thereof as medicines |
| 04/12/2001 | CA2385961A1 Agents for reducing cholesterol-uptake and liquid-uptake |
| 04/12/2001 | CA2385703A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 04/12/2001 | CA2385551A1 Metal-binding compounds and uses therefor |
| 04/12/2001 | CA2385251A1 Novel imidazopyridine carbonitrile compounds |
| 04/12/2001 | CA2385244A1 Novel nicotinonitrile compounds |
| 04/12/2001 | CA2385210A1 Novel trisubstituted pyridine compounds |
| 04/12/2001 | CA2385127A1 Novel hepatoma-derived growth factor-like proteins, polynulceotides encoding them and methods of use |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2380807A1 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
| 04/12/2001 | CA2379462A1 Human g-protein coupled receptor |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090989A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090926A1 Human G-protein coupled receptor |
| 04/11/2001 | EP1090912A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 04/11/2001 | EP1090908A2 Cyclobutane derivatives as inhibitors of protein farnesyltransferase |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090634A1 Agents for reducing cholesterol and lipid uptake |
| 04/11/2001 | EP1090130A1 Protein c derivatives |
| 04/11/2001 | EP1090118A2 Human signal peptide-containing proteins |
| 04/11/2001 | EP1090105A1 Ependymal neural stem cells and method for their isolation |
| 04/11/2001 | EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same |
| 04/11/2001 | EP1090019A1 Adenosine derivatives |
| 04/11/2001 | EP1090017A1 NOVEL COMPOUNDS DERIVED FROM $g(a)-D-XYLOSE, PREPARATION METHOD AND THERAPEUTIC USE |
| 04/11/2001 | EP1090014A1 Arylsulfonanilide phosphates |
| 04/11/2001 | EP1090012A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090011A1 Inhibitors of prenyl-protein transferase |
| 04/11/2001 | EP1090003A1 7-alkyl- and cycloalkyl-substituted imidazotriazinones |
| 04/11/2001 | EP1089994A1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 04/11/2001 | EP1089989A1 Inhibitors of alpha4beta1 mediated cell adhesion |
| 04/11/2001 | EP1089968A1 Thyroid hormone analogues and methods for their preparation |
| 04/11/2001 | EP1089964A1 Hydrazine derivatives |
| 04/11/2001 | EP1089872A1 Multi-action particle for structuring biological media |
| 04/11/2001 | EP1089752A1 Alpha-keto oxadiazoles as serine protease inhibitors |
| 04/11/2001 | EP1089737A2 Method of treating pulmonary hypertension |
| 04/11/2001 | EP1089735A1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists |
| 04/11/2001 | EP1089733A2 Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| 04/11/2001 | EP1089732A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089731A1 Compositions and methods for treating elevated blood cholesterol |
| 04/11/2001 | EP1089728A1 Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
| 04/11/2001 | EP1089723A1 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
| 04/11/2001 | EP0984963B1 Novel compounds |
| 04/11/2001 | CN1291238A Process for obtaining of HMG-CO A reductase inhibitors of high purify |
| 04/11/2001 | CN1291193A Novel triazolo (4.5-d) pyrimidine compounds |
| 04/11/2001 | CN1291190A 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonist |
| 04/11/2001 | CN1291184A Cycloalkene derivatives, process for producing the same and use |
| 04/11/2001 | CN1291183A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 04/11/2001 | CN1291178A E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl) phenoxy] ethanol and pharmaceutical compositions thereof |
| 04/11/2001 | CN1291094A Bicyclic pyrrole derivatives as MCP-1 inhibitor |
| 04/11/2001 | CN1290703A New metal protease inhibitors, its preparing method and their medicinal composition containing them |
| 04/11/2001 | CN1290701A Flavone chromium and its producing method and use |
| 04/11/2001 | CN1290698A Quinoline-4-base deviative I |
| 04/11/2001 | CN1290551A Method for preparing medicinal liquid for curing angiocardiopathy |
| 04/11/2001 | CN1290547A Medicine powder for curing angitis and its preparing method |
| 04/11/2001 | CN1290536A Capsule for cerebral thrombosis and high blood pressure |
| 04/11/2001 | CN1290532A Method for preparing Chinese medicine for curing apoplexy and hemiparalysis |
| 04/11/2001 | CN1064361C Xanthine compounds having terminally aminated alkynol side chains |
| 04/11/2001 | CN1064358C Benyl piperidine derivatives |
| 04/11/2001 | CN1064354C Trilcyclic benzazepine vasopressin antagnonists |
| 04/11/2001 | CN1064352C Novel cyloakyl derivatives and inhibitors of bone resorption and vitronection receptor antagonists |
| 04/11/2001 | CN1064351C Substituted indanylidineacetylguanidine, process for their paraparation, their use as medicaments ofdiagonstic and medicaments containing them |
| 04/11/2001 | CN1064350C Aryl and heteroaryl alkoxynaphtalene derivatives |
| 04/11/2001 | CN1064349C Novel tricyclic amide, its preparing method and medicinal composition |
| 04/11/2001 | CN1064263C Medicine for curing angiocardiopathy |
| 04/11/2001 | CN1064232C Non freeze-drying powder injection of heart disease curing medicine and preparing method |
| 04/10/2001 | US6215002 Cyclization, deblocking, deprotection, sulfonation, condensation, amidation; antiinflammatory agents; respiratory system disorders |